Searched for
ANTIEPILEPTIC DRUG
True North buys 25% stake in pharma co EmbioPrivate equity firm True North is investing approximately $50 million in Embio Ltd. Embio manufactures Active Pharmaceutical Ingredients fo...- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Alembic Pharma gets USFDA nod for generic drugAlembic Pharmaceuticals has secured approval from the US health regulator for a generic seizure medication. The company received final clea...
- Dr Reddy's, Lupin recall products in US due to labelling, manufacturing errors: USFDADr. Reddy's Laboratories and Lupin are recalling products in the US due to labeling and manufacturing issues. Dr. Reddy's is recalling an a...
- Zydus Lifesciences gets USFDA nod to sell generic anti-epileptic medicationZydus Lifesciences has received approval from the US FDA to market Lacosamide Tablets, a generic anti-epileptic medication used to treat pa...
- USFDA rules against Sun Pharma Advanced Research Co's appeal regarding cancer drug applicationThe Office of New Drugs (OND) of the US Food and Drug Administration (FDA) has denied the company's appeal of the Complete Response Letter ...
- Dr Reddy's launches generic epilepsy drug in US market"We are pleased that this product has been designated as a Competitive Generic Therapy (CGT) by the FDA," Dr Reddy's Laboratories North Ame...
- Some drugs more essential, govt moves to ensure supplyThe government has identified 55 drugs that hospitals in India need to manage coronavirus patients in intensive care units.
- SPARC plunges 10% as USFDA rejects application for cancer drug TaclantisThe company informed this to the exchanges after market hours of Tuesday.
- Sun Pharma arm gets USFDA nod for epilepsy drugThe subsidiary concerned had in-licensed Elepsia XR from Sun Pharma Advanced Research Company (SPARC) in July 2016.
- SPARC, Sun Pharma slide as USFDA rescinds approval to drugShares of Sun Pharma Advanced Research Company today fell by almost 3 per cent as the US health regulator has revoked its earlier approval ...
- Aurobindo Pharma gets USFDA final nod for generic anti-epileptic drugAurobindo Pharma has received final nod from the US health regulator to make and market generic anti-epileptic Phenytoin Sodium capsules in...
- Sun Pharma has potential to gain another 15-20%: Mayuresh Joshi, Angel BrokingJoshi points out that after the merger with Ranbaxy, the drug maker will cover all the niche area, all possible segments of the generic mar...
- SPARC gets USFDA nod for its anti-epileptic drug ELEPSIA XR"Approval of ELEPSIA XRTM as 1,000 mg and 1,500 mg once a day tablets will be very useful for these patients and physicians."
- Glenmark gets USFDA nod for anti-epileptic drugGlenmark Pharmaceuticals today said its US-based arm has received approval from the US health regulator to market generic Lamictal tablets.
- Lupin gets final US FDA nod for generic anti-epileptic drugLupin is the 5th largest generics player in the US (by prescriptions), the only Asian company to achieve that distinction.
- Orchid receives USFDA nod for anti-epileptic tabletsOrchid Chemicals & Pharmaceuticals said it has received US FDA's approval to sell anti-epileptic levetiracetam tablets in the American mark...
- Orchid, Glenmark, Lupin & Aurobindo Pharma get US nod for LevetiracetamOrchid Pharmaceuticals, Glenmark Pharmaceuticals, Lupin and Aurobindo Pharmaceuticals have all received US FDA approval for their abbreviat...
- Glenmark gets tentative FDA nod for TopiramteGlenmark Pharmaceuticals says it has received the USFDA tentative approval to market Topiramate tablets.
- Wockhardt gets nod for new drugWockhardt Ltd has received tentative approval from the USFDA for anti-epileptic drug, Divalproex Sodium delayed-release tablets.
Load More
